Trial intelligence / Profile preview

Alectinib in EGFR/HER2 Altered Advanced NSCLC

CTR20150258Phase 2Active

Sponsor

Allist Pharmaceuticals

Start

May 2015

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1